ICER Finds Covid Vaccines Cost-Effective at $73-$177 for All U.S. Groups
Updated
Updated · POLITICO · Jun 15
ICER Finds Covid Vaccines Cost-Effective at $73-$177 for All U.S. Groups
2 articles · Updated · POLITICO · Jun 15
Summary
An updated ICER analysis found Covid-19 vaccination for the 2026-2027 season would be cost-effective for every U.S. subpopulation at current prices.
Prices ranging from $73 to $177 still deliver the strongest value for pregnant women, infants ages 6 months to 1 year, and adults 65 and older, even as severe Covid cases have declined.
The review covered shots from Pfizer-BioNTech, Moderna and Sanofi and stressed that year-round infections can still lead to serious illness or death.
ICER said the report does not make public health recommendations, but it adds economic support for continued vaccination ahead of the coming season.